Glenmede Trust’s Doximity DOCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-41,181
Closed -$1.82M 1495
2025
Q4
$1.82M Buy
+41,181
New +$2.31M 0.01% 584
2025
Q1
$10.2M Buy
+175,434
New +$11.1M 0.05% 350
2024
Q2
Sell
-77,825
Closed -$2.09M 1367
2024
Q1
$2.09M Buy
+77,825
New +$2.22M 0.01% 556
2022
Q3
Sell
-80,421
Closed -$2.8M 1283
2022
Q2
$2.8M Hold
80,421
0.02% 476
2022
Q1
$4.19M Buy
+80,421
New +$4.05M 0.02% 437

Other funds holding DOCS

Glenmede Trust's DOCS Position: Q1 2026 in Review

Glenmede Trust sold out of Doximity (DOCS) in Q1 2026, closing a stake of 41,181 shares — an estimated $1.82M sold.

Glenmede Trust first reported a position in DOCS in Q1 2022 and held it in 5 quarters. The position peaked at $10.2M in Q1 2025. 419 funds tracked by Wall St. Rank hold DOCS as of Q1 2026.

  • Glenmede Trust reported no remaining Doximity position as of Q1 2026 after selling out during the quarter.
  • Glenmede Trust sold 41,181 Doximity shares in Q1 2026, an estimated $1.82M.
  • Glenmede Trust first reported a position in Doximity in Q1 2022 and held it in 5 quarters.
  • Glenmede Trust's Doximity position peaked at $10.2M in Q1 2025.
  • 419 funds tracked by Wall St. Rank held Doximity as of Q1 2026.

Based on Glenmede Trust's 13F filing for Q1 2026, filed 26 May 2026.